Polysatrifo Chinese medicinal oral preparation and its making method

A technology of oral preparations and traditional Chinese medicines, which is applied in the direction of medical formulas, drug combinations, and medical preparations containing active ingredients, etc., can solve the problems of high stroke mortality, high medical rehabilitation costs, and high 5-year recurrence rate, and achieve a reduction Whole blood viscosity, improvement of ischemia and hypoxia, and improvement of platelet viscosity

Inactive Publication Date: 2011-03-16
北京普惠天悦生物科技有限公司 +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Stroke disease has high mortality rate (22%-68%), high disability rate, high 5-year recurrence rate (30%-50%) and high medical

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0060] Example 1

[0061] Polysaccharide Chinese medicine capsule is characterized in that it contains Chinese medicine A and B, and its component distribution ratio (parts by weight) is calculated as crude drug: A:B=60:40

[0062] The preparation method of the polysaccharide Chinese medicine capsule of the present invention is characterized in that: the preparation method of the active ingredient of traditional Chinese medicine A and the active ingredient of traditional Chinese medicine B are as follows:

[0063] The preparation method of the active ingredient of the traditional Chinese medicine A: take the medicinal material of Astragalus, add water and decoct three times for 2 hours each time, combine the decoction, filter, concentrate to a relative density of 1.15-1.20 (50° C.), add ethanol to make the alcohol content 80%, Let stand for 24 hours, filter, and take the precipitate. The precipitate was dried at low temperature, the obtained dried product was dissolved in di...

Example Embodiment

[0066] Example 2

[0067] Polysaccharide azine traditional Chinese medicine granules are characterized in that they contain traditional Chinese medicines A and B, and the composition ratio (parts by weight) is calculated as crude drug: A:B=60:40

[0068] The preparation method of the polysaccharide Chinese medicine capsule of the present invention is characterized in that: the preparation method of the active ingredient of the traditional Chinese medicine A and the active ingredient of the traditional Chinese medicine B is as follows:

[0069] The preparation method of the active ingredient of the traditional Chinese medicine A: take the medicinal material of Astragalus, add water and decoct three times for 2 hours each time, combine the decoction, filter, concentrate to a relative density of 1.15-1.20 (50° C.), add ethanol to make the alcohol content 80%, Let stand for 24 hours, filter, and take the precipitate. The precipitate was dried at low temperature, the obtained dr...

Example Embodiment

[0072] Example 3

[0073] The polysaccharide Chinese medicine tablet is characterized in that it contains Chinese medicine A and B, and its component distribution ratio (parts by weight) is calculated as crude drug: A:B=60:40

[0074] The preparation method of the polysaccharide Chinese medicine tablet of the present invention is characterized in that: the preparation method of the active ingredient of the traditional Chinese medicine A and the active ingredient of the traditional Chinese medicine B is as follows:

[0075] The preparation method of the active ingredient of the traditional Chinese medicine A: take the medicinal material of Astragalus, add water and decoct three times for 2 hours each time, combine the decoction, filter, concentrate to a relative density of 1.15-1.20 (50° C.), add ethanol to make the alcohol content 80%, Let stand for 24 hours, filter, and take the precipitate. The precipitate was dried at low temperature, the obtained dried product was disso...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

An orally taken Chinese medicine containing astragalose and chuanxiongzine for treating cerebral thrombosis, cerebral hemorrhage and their sequelae is prepared from astragalus root and Chuan-xiong rhizome through respectively extracting. Their extracting processes are also disclosed.

Description

technical field [0001] The invention relates to a polysaccharazine traditional Chinese medicine oral preparation and a preparation method thereof, belonging to the medical technology. Background technique [0002] With the development of global society and economy, the spectrum of human diseases is undergoing profound changes, and stroke has become the top one-third of the causes of human death. According to the statistical analysis of death reports from various countries and regions in the world, about 4.6 million people die of stroke every year in the world, 3 / 4 of which occur in developing countries, and this gap is still developing. In the United States, stroke is the third leading cause of death and one of the leading causes of severe, long-term disability among adults. Each year about 500,000 people have a first-time stroke, and about 167,000 deaths are stroke-related. Cerebral apoplexy has a high mortality rate (22%-68%), high disability rate, high 5-year recurrence...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/715A61K31/4965A61K36/481A61K36/236A61K9/10A61P9/10
Inventor 高普
Owner 北京普惠天悦生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products